Navigation Links
Ampio Pharmaceuticals Announces Pricing of Public Offering of 4,615,400 Shares of Common Stock
Date:7/12/2012

GREENWOOD VILLAGE, Colo., July 12, 2012 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (Nasdaq:   AMPE), a biopharmaceutical company conducting clinical trials on its three lead drugs (Ampion™, Optina™ & Zertane™), licensing distribution of these drugs and developing additional new drugs, today announced the pricing of its previously announced underwritten public offering of 4,615,400 shares of its common stock, offered at a price to the public of $3.25 per share.  The gross proceeds to Ampio from this offering are expected to be $15.0 million, before deducting the underwriting discount and other estimated offering expenses payable by Ampio.  Ampio and certain of its stockholders have granted the underwriters a 45-day option to purchase at the public offering price up to an aggregate of 692,310 additional shares of common stock to cover overallotments, if any. The offering is expected to close on or about July 18, 2012, subject to customary closing conditions.

(Logo:  http://photos.prnewswire.com/prnh/20120516/MM09116LOGO)

Aegis Capital Corp. and Fordham Financial Management, Inc. are acting as joint book-running managers for the offering.

The offering is being made pursuant to a shelf registration statement that Ampio filed with the Securities and Exchange Commission ("SEC") and is effective.  A preliminary prospectus supplement and accompanying base prospectus relating to the offering were filed with the SEC and a final prospectus supplement and accompanying base prospectus will be filed with the SEC.  When available, copies of the final prospectus supplement and accompanying base prospectus relating to the offering may be obtained by contacting Aegis Capital Corp., Prospectus Department, 810 Seventh Avenue, 18th Floor, New York, NY, 10019, telephone: 212-813-1010 or email: pros
'/>"/>

SOURCE Ampio Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Ampio Pharmaceuticals Announces Proposed Public Offering
2. Ampios CEO and CSO Send Message to Shareholders
3. Four-Time Triathlon World Champion Melanie McQuaid Selects Polar USA as Official Heart Rate Training Solution
4. Ampio Pharmaceuticals Schedules 2012 Update Webcast
5. Four Californians Selected As Breakaway from Cancer® Champions To Be Honored During Amgen Tour of California
6. Ampio Awarded US and Canadian Patents that will Bolster the Commercialization of Optina™ for the treatment of Diabetic Macular Edema (DME)
7. Cumberland Pharmaceuticals To Announce Second Quarter 2012 Financial Results On August 2, 2012
8. Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2012 Financial Results
9. Arena Pharmaceuticals Files Marketing Authorization Application in Switzerland for Lorcaserin as a Treatment for Weight Control
10. AcelRx Pharmaceuticals, Inc. to Webcast, Live, at RetailInvestorConferences.com on July 12th
11. Acella Pharmaceuticals, LLC, files Abbreviated New Drug Application (ANDA) With the U.S. Food & Drug Administration for Topical Corticosteroids Lotion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... YORK , Sept. 30, 2014 The ... Growing ageing population and rise in the incidence of ... chronic wounds and in affordability of better quality of ... wound care market. Universal coverage of public health insurance ... would further stimulate demand. Based on the findings of ...
(Date:9/30/2014)... 2014  HealthLoop® released an app version of its ... 8 and allows people to share medical device and ... iOS technologies to enhance the HealthLoop experience for iPhone ... their doctors between visits. "This new ... collect is exciting," says HealthLoop founder Dr. Jordan ...
(Date:9/30/2014)... , Sept. 30, 2014 The Eastern ... Both established medical-device providers as well as new medical-device ... region, while simultaneously looking at ways to reduce the ... Using distributors is one of the effective means to ... devices distribution market in Eastern European and provides profiles ...
Breaking Medicine Technology:China Wound Care Market 2China Wound Care Market 3HealthLoop Integrates with Apple's HealthKit Enabling Patients to Share Health Data with Their Doctors Right from their iPhone 2Medical Technologies Distributor Profiles in Eastern Europe 2Medical Technologies Distributor Profiles in Eastern Europe 3
... Patients For Over a Decade, SAN FRANCISCO, ... benefit from arthroscopic surgery long term,according to a ... for Sports Medicine Specialty Day at The Moscone ... surgery, rather than conservative,methods, yielded excellent results., ...
... LARGO, Fla., March 7 AlphaMed Pharmaceuticals,Corporation announced ... version of the therapeutic protein alpha 1-antitrypsin (AAT).,AlphaMed ... production system in yeast. The yeast has been ... that which is,manufactured by the human body., ...
Cached Medicine Technology:Controversial Shoulder Surgery for First-time Dislocation Proven Effective Long-Term 2Controversial Shoulder Surgery for First-time Dislocation Proven Effective Long-Term 3AlphaMed Pharmaceuticals Announces Breakthrough in the Development of Recombinant Alpha 1-Antitrypsin 2
(Date:9/30/2014)... 30, 2014 A group of Americans is ... an epidemic that, left unchecked, could create a catastrophic, global ... headed to Africa. John Rogers, the Executive Director the Eugene ... to fight a disease most think mankind conquered long ago: ... years ago is on the comeback in several countries - ...
(Date:9/30/2014)... 2014 Two revolutionary procedures now being utilized ... gum disease a far less painful and far more ... you’ve ever felt electric shock waves surge through your teeth ... beverage, it’s possible you already know the impact of receding ... general dentist in West Palm Beach, and a Fellow in ...
(Date:9/30/2014)... (HealthDay News) -- Medicare should cover low-dose computed tomography ... the disease, a coalition of more than 60 patient ... the Lung Cancer Alliance, the Society of Thoracic Surgeons, ... and the American Society of Clinical Oncology, made its ... Centers for Medicare & Medicaid Services (CMS). Such ...
(Date:9/30/2014)... Defense has made progress in reducing the stigma associated ... and post-traumatic stress disorder, but more improvement is still ... Despite efforts of both the Defense Department and the ... service members still do not seek needed care for ... concerted effort to promote treatment as a way to ...
(Date:9/30/2014)... that causes a rare premature aging disease could lead ... unstoppable cell division that makes cancer so deadly. ... U-M Health System recently discovered a protein mutation that ... hematopoietic stem cells can,t regenerate and make new blood. ... cancer and bone marrow failure. , But the ...
Breaking Medicine News(10 mins):Health News:US Delegation Heads to North Korea to Combat Tuberculosis Epidemic 2Health News:Florida Dentist Battles Gum Disease With Latest Techniques 2Health News:Florida Dentist Battles Gum Disease With Latest Techniques 3Health News:Groups Call for Medicare Coverage of Lung Cancer Screening 2Health News:US military making progress reducing stigma tied to seeking help for mental illness 2Health News:US military making progress reducing stigma tied to seeking help for mental illness 3Health News:Disease decoded: Gene mutation may lead to development of new cancer drugs 2
... Nutrition Month(R), and Cabot Creamery Cooperative(R) offers, ... they age, CABOT, Vt., Feb. 19 March ... Dietetic Association,s campaign to promote,the importance of eating a ... to eat better, smarter and,healthier. Research by the US ...
... Harvard-Trained Cosmetic and Laser,Surgeon and Board Certified ... Relations to spearhead her PR campaign. Dr. Jacob,Director ... performs a variety of medical procedures and services, ... A veteran in the field, Dr. Jacob works ...
... Hyperactivity Disorder in ... Throughout Asia -, NEW HAVEN, Conn. and KORTRIJK, ... specialty pharmaceuticals company,focused on bringing proprietary medicines to the ... announced that RHEI has,licensed from MethaPharma the exclusive right ...
... Feb. 18 The following was,released today by ... Ambulance diversion? Crowded,emergency departments? Reports and articles over ... longer emergency department wait times (in,excess of 12 ... than one,third of area hospitals were to divert ...
... An international team of scientists led by a University ... into the realm of consciousness. , The scientists have ... perception, by showing how single neurons in the human ... of Leicester bioengineer Dr Rodrigo Quian Quiroga is spearheading ...
... atrial fibrillation, analysis shows , , MONDAY, Feb. 18 (HealthDay ... that are prescribed to lower cholesterol levels may also ... that boosts the odds of a stroke, French researchers ... more than 3,500 participants showed that those patients who ...
Cached Medicine News:Health News:Hey Boomers, Here's to Your Health! 2Health News:Hey Boomers, Here's to Your Health! 3Health News:Hey Boomers, Here's to Your Health! 4Health News:Hey Boomers, Here's to Your Health! 5Health News:Dr. Carolyn Jacob Hires Empower Public Relations 2Health News:RHEI Pharmaceuticals Licenses Attental From MethaPharma (Vemedia Group) for Distribution Throughout Asia 2Health News:RHEI Pharmaceuticals Licenses Attental From MethaPharma (Vemedia Group) for Distribution Throughout Asia 3Health News:Gilbert Hospital Turns the Tables on the Flu 2Health News:Scientists explore consciousness 2Health News:Scientists explore consciousness 3Health News:Cholesterol-Lowering Drugs May Ease Irregular Heartbeat 2Health News:Cholesterol-Lowering Drugs May Ease Irregular Heartbeat 3
... spinal procedures. The SpineAssist platform for enhancing ... solution that enables surgery to be performed ... currently answers a growing need for accurate ... pedicle screw insertion for spine fusion procedures. ...
ACRYSOF®, Posterior Chamber Intraocular Lenses are indicated for the replacement of the human lens to achieve visual correction of aphakia in patients sixty years and older. These lenses are i...
Single piece PMMA lens, AC depth: 4.7....
Single-Piece PMMA IOLs for the replacement of the human crystalline lens in the visual correction of aphakia....
Medicine Products: